Paper20028824
Elucidation of the pharmacokinetic/pharmacodynamic determinant of colistin activity against Pseudomonas aeruginosa in murine thigh and lung infection models.
Dudhani RV and 6 others. Antimicrob Agents Chemother, 2010. Cited by 161 papers, by iCite.
Cite this record
ConductScience Library. Elucidation of the pharmacokinetic/pharmacodynamic determinant of colistin activity against Pseudomonas aeruginosa in murine thigh and lung infection models. Papers, record 20028824. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20028824
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anti-Bacterial Agents | Major topic |
| Colistin | Major topic |
| Disease Models, Animal | Major topic |
| Lung Diseases | Major topic |
| Pseudomonas Infections | Major topic |
| Pseudomonas aeruginosa | Major topic |
| Thigh | Major topic |
| Animals | |
| Area Under Curve | |
| Female | |
| Humans | |
| Lung | |
| Mice | |
| Microbial Sensitivity Tests | |
| Neutropenia | |
| Specific Pathogen-Free Organisms |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 AI070896 | NIAID NIH HHS | United States | R01AI070896 | PubMed and NIH | NIH RePORTER |
| R01 AI079330 | NIAID NIH HHS | United States | R01AI079330 | PubMed and NIH | NIH RePORTER |
| R01AI079330 | NIAID NIH HHS | United States | R01AI079330 | PubMed and NIH | NIH RePORTER |
| R01AI070896 | NIAID NIH HHS | United States | R01AI070896 | PubMed and NIH | NIH RePORTER |
References28
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 17182346 | Anti-infective research and development--problems, challenges, and solutions. | Lancet Infect Dis | 2007 | https://conductscience.org/library/papers/17182346 | PubMed |
| 2 | 16931410 | Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections. | Lancet Infect Dis | 2006 | https://conductscience.org/library/papers/16931410 | PubMed |
| 3 | 8161713 | Dose-dependent pharmacokinetics: experimental observations and theoretical considerations. | Biopharm Drug Dispos | 1994 | https://conductscience.org/library/papers/8161713 | PubMed |
| 4 | 11587346 | A simple method for the assay of colistin in human plasma, using pre-column derivatization with 9-fluorenylmethyl chloroformate in solid-phase extraction cartridges and reversed-phase high-performance liquid chromatography. | J Chromatogr B Biomed Sci Appl | 2001 | https://conductscience.org/library/papers/11587346 | PubMed |
| 5 | 18343250 | Colistin serum concentrations after intravenous administration in critically ill patients with serious multidrug-resistant, gram-negative bacilli infections: a prospective, open-label, uncontrolled study. | Clin Ther | 2008 | https://conductscience.org/library/papers/18343250 | PubMed |
| 6 | 6842025 | Impact of dosing intervals on activity of gentamicin and ticarcillin against Pseudomonas aeruginosa in granulocytopenic mice. | J Infect Dis | 1983 | https://conductscience.org/library/papers/6842025 | PubMed |
| 7 | 18180359 | Subacute toxicity of colistin methanesulfonate in rats: comparison of various intravenous dosage regimens. | Antimicrob Agents Chemother | 2008 | https://conductscience.org/library/papers/18180359 | PubMed |
| 8 | 7624896 | Changes in the serum protein binding of vancomycin in patients with methicillin-resistant Staphylococcus aureus infection: the role of serum alpha 1-acid glycoprotein levels. | Ther Drug Monit | 1995 | https://conductscience.org/library/papers/7624896 | PubMed |
| 9 | 18227094 | Comparison of once-, twice- and thrice-daily dosing of colistin on antibacterial effect and emergence of resistance: studies with Pseudomonas aeruginosa in an in vitro pharmacodynamic model. | J Antimicrob Chemother | 2008 | https://conductscience.org/library/papers/18227094 | PubMed |
| 10 | 180874 | Significance of serum protein and tissue binding of antimicrobial agents. | Annu Rev Med | 1976 | https://conductscience.org/library/papers/180874 | PubMed |
| 11 | 18358794 | Spread of colistin resistant non-mucoid Pseudomonas aeruginosa among chronically infected Danish cystic fibrosis patients. | J Cyst Fibros | 2008 | https://conductscience.org/library/papers/18358794 | PubMed |
| 12 | 17159923 | Drugs for bad bugs: confronting the challenges of antibacterial discovery. | Nat Rev Drug Discov | 2007 | https://conductscience.org/library/papers/17159923 | PubMed |
| 13 | 16251342 | Pharmacokinetics of colistin methanesulfonate and colistin in a critically ill patient receiving continuous venovenous hemodiafiltration. | Antimicrob Agents Chemother | 2005 | https://conductscience.org/library/papers/16251342 | PubMed |
| 14 | 19433570 | Population pharmacokinetic analysis of colistin methanesulfonate and colistin after intravenous administration in critically ill patients with infections caused by gram-negative bacteria. | Antimicrob Agents Chemother | 2009 | https://conductscience.org/library/papers/19433570 | PubMed |
| 15 | 18625681 | Polymyxins revisited. | Clin Microbiol Rev | 2008 | https://conductscience.org/library/papers/18625681 | PubMed |
| 16 | 14585859 | Steady-state pharmacokinetics of intravenous colistin methanesulphonate in patients with cystic fibrosis. | J Antimicrob Chemother | 2003 | https://conductscience.org/library/papers/14585859 | PubMed |
| 17 | 3139779 | Correlation of antimicrobial pharmacokinetic parameters with therapeutic efficacy in an animal model. | J Infect Dis | 1988 | https://conductscience.org/library/papers/3139779 | PubMed |
| 18 | 11181360 | In vitro pharmacodynamic properties of colistin and colistin methanesulfonate against Pseudomonas aeruginosa isolates from patients with cystic fibrosis. | Antimicrob Agents Chemother | 2001 | https://conductscience.org/library/papers/11181360 | PubMed |
| 19 | 16447111 | Bad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America. | Clin Infect Dis | 2006 | https://conductscience.org/library/papers/16447111 | PubMed |
| 20 | 6181800 | Serum levels of acute phase and cardiac proteins after myocardial infarction, surgery, and infection. | Br Heart J | 1982 | https://conductscience.org/library/papers/6181800 | PubMed |
Cited by83
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 161 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42938753 | In Vitro and In Vivo Efficacy of the Broad-Spectrum β-Lactamase Inhibitor APC24-7 in Combination with Meropenem Against Carbapenem-Resistant Enterobacterales. | Antibiotics (Basel) | 2026 | https://conductscience.org/library/papers/42938753 | PubMed |
| 42921313 | Antimicrobial Peptides Beyond the Petri Dish: Translational Barriers to Therapeutic Development. | ACS Bio Med Chem Au | 2026 | https://conductscience.org/library/papers/42921313 | PubMed |
| 41787258 | Combination of 7-hydroxyflavone and colistin: antibacterial activity and mechanism against multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii. | BMC Microbiol | 2026 | https://conductscience.org/library/papers/41787258 | PubMed |
| 41746140 | Pharmacodynamic evaluation of BRII-693, a next-generation synthetic macrocyclic peptide antibiotic, in the neutropenic mouse thigh and lung infection models against gram-negative pathogens. | Antimicrob Agents Chemother | 2026 | https://conductscience.org/library/papers/41746140 | PubMed |
| 41405421 | Systematic review of antimicrobial pharmacokinetic/pharmacodynamic indices in murine thigh and hollow fibre dose fractionation studies analysed with a standard method. | J Antimicrob Chemother | 2026 | https://conductscience.org/library/papers/41405421 | PubMed |
| 41368010 | Drug-resistant gram-negative bacterial infections in children in the Oceania region: review of the epidemiology, antimicrobial availability, treatment, clinical trial and pharmacokinetic data, and key evidence gaps. | Lancet Reg Health West Pac | 2025 | https://conductscience.org/library/papers/41368010 | PubMed |
| 41222983 | Second-generation lysocins as therapeutics for treating Pseudomonas aeruginosa infections. | Antimicrob Agents Chemother | 2025 | https://conductscience.org/library/papers/41222983 | PubMed |
| 41053828 | Pseudomonas aeruginosa infection exacerbates elastase induced lung damage: characterisation of a novel murine two-hit model of pulmonary infection. | Respir Res | 2025 | https://conductscience.org/library/papers/41053828 | PubMed |
| 40547403 | Development of an LC-MS/MS method for quantification of colistin and colistin methanesulfonate in human plasma and its application to stability studies and therapeutic drug monitoring. | J Mass Spectrom Adv Clin Lab | 2025 | https://conductscience.org/library/papers/40547403 | PubMed |
| 40426512 | The α-Helical Amphipathic Peptide Alleviates Colistin-Induced Nephrotoxicity by Maintaining Mitochondrial Function in Both In Vitro and In Vivo Infection Models. | Antibiotics (Basel) | 2025 | https://conductscience.org/library/papers/40426512 | PubMed |
| 39066828 | Decoding the TAome and computational insights into parDE toxin-antitoxin systems in Pseudomonas aeruginosa. | Arch Microbiol | 2024 | https://conductscience.org/library/papers/39066828 | PubMed |
| 38998921 | Colistin: Lights and Shadows of an Older Antibiotic. | Molecules | 2024 | https://conductscience.org/library/papers/38998921 | PubMed |
| 38646595 | Dextrin conjugation to colistin inhibits its toxicity, cellular uptake and acute kidney injury in vivo. | RSC Pharm | 2024 | https://conductscience.org/library/papers/38646595 | PubMed |
| 37676873 | Development of an antibody fused with an antimicrobial peptide targeting Pseudomonas aeruginosa: A new approach to prevent and treat bacterial infections. | PLoS Pathog | 2023 | https://conductscience.org/library/papers/37676873 | PubMed |
| 37550398 | Targeted dosing for susceptible heteroresistant subpopulations may improve rational dosage regimen prediction for colistin in broiler chickens. | Sci Rep | 2023 | https://conductscience.org/library/papers/37550398 | PubMed |
| 37022170 | In Vivo Pharmacodynamic Profile of EVER206, a Novel Polymyxin Antimicrobial, against Gram-Negative Bacteria in the Murine Thigh Infection Model. | Antimicrob Agents Chemother | 2023 | https://conductscience.org/library/papers/37022170 | PubMed |
| 36751699 | Chinese consensus guidelines for therapeutic drug monitoring of polymyxin B, endorsed by the Infection and Chemotherapy Committee of the Shanghai Medical Association and the Therapeutic Drug Monitoring Committee of the Chinese Pharmacological Society. | J Zhejiang Univ Sci B | 2023 | https://conductscience.org/library/papers/36751699 | PubMed |
| 36718051 | Pharmacokinetic and pharmacodynamic properties of polymyxin B in Escherichia coli and Klebsiella pneumoniae murine infection models. | J Antimicrob Chemother | 2023 | https://conductscience.org/library/papers/36718051 | PubMed |
| 36588676 | Pharmacokinetics/pharmacodynamics of polymyxin B in patients with bloodstream infection caused by carbapenem-resistant Klebsiella pneumoniae. | Front Pharmacol | 2022 | https://conductscience.org/library/papers/36588676 | PubMed |
| 36558952 | Assessing Clinical Potential of Old Antibiotics against Severe Infections by Multi-Drug-Resistant Gram-Negative Bacteria Using In Silico Modelling. | Pharmaceuticals (Basel) | 2022 | https://conductscience.org/library/papers/36558952 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/20028824
GET https://conductscience.org/api/papers/v1/20028824/references?page=2